A new ligand extends the half-life of peptide drugs from minutes to days

EPFL scientists have developed a ligand molecule that connects peptide drugs to blood-serum albumin and keeps them from being cleared out by the kidneys too soon. The ligand is easy to synthesize and can extend the half-life of therapeutic peptides from minutes to several days.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

More #news: